Global Myasthenia Gravis Treatment Market: Forecast and Trends

Report Highlights

The global market for myasthenia gravis treatment is estimated to increase from $1.3 billion in 2023 to reach $2.2 billion by 2028, at a compound annual growth rate (CAGR) of 10.5% from 2023 through 2028.

Report Includes

• 54 data tables and 47 additional tables
• An overview and analysis of the global market for myasthenia gravis (MG) treatments
• Analyses of market trends, with historical market revenue data (sales figures) for 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Estimates of the market size, revenue forecasts and potential growth share analysis for MG treatments based on product, type, treatment modality, and region
• In-depth information (facts and figures) pertaining to the major factors influencing the market (drivers, restraints, opportunities and challenges)
• Analysis of the market growth opportunities through Porter’s Five Forces and PESTLE analyses, taking into consideration the prevailing micro- and macro environmental factors
• An examination of the importance of ESG in the myasthenia gravis market, taking into account consumer attitudes, risks and opportunities, and the ESG practices of pharmaceutical and biotech companies
• Discussion of the factors driving the market, industry trends and new developments
• Analysis of relevant patents
• Identification of the leaders in the field of MG
• Profiles of the leading market players, including Profiles of the leading market players, including AbbVie, Bausch Health, Gilead Sciences, Merck & Co. Inc., Servier, and Teva

Report Scope

This report aims to study the myasthenia gravis treatment global market size comprehensively. Current and historical market revenues can be estimated based on the product type, treatment by drug and region.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Consulting Editor’s Credentials

Melissa Dueck brings more than 25 years of health industry experience to the consulting analyst role with expertise in pharmaceuticals, medical technologies, and hospital operations. Ms. Dueck holds an MBA in Health Care Management, an MPH in Global Health, and is a pending doctoral candidate. She has authored several industry-specific documents and is a well-respected, trusted contributor to the market intelligence community. Her writings are published in magazines, newspapers, and professional journals. She is also an experienced custom market research writer who has worked with a large variety of clients in many fields who require innumerable variations to research documents. Ms. Dueck serves the health and medical community through emergency room medical training, healthcare information system coordination, program implementation and evaluations, and strategic business oversight planning.